Want to see EWTX full AI Analyst Report?
Edgewise Therapeutics (EWTX) Stock Forecast & Price Target
439 Followers
EWTX Analyst Ratings
Strong Buy
10Buy2Hold0Sell
Based on 12 analysts giving stock ratings to Edgewise Therapeutics in the past 3 months
EWTX Stock 12 Month Forecast
Average Price Target
$54.30▲(39.70% Upside)Based on 12 Wall Street analysts offering 12 month price targets for Edgewise Therapeutics in the last 3 months. The average price target is $54.30 with a high forecast of $85.00 and a low forecast of $36.00. The average price target represents a 39.70% change from the last price of $38.87.
Past 12 Months12 Month ForecastJan2026Oct2026
High$85.00
Average$54.30
Low$36.00
Highest Price TargetHighest$85.00Average Price Target$54.30Lowest Price TargetLowest$36.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Laura Chico | Wedbush | $51 | buy | 31.21%Upside | Reiterated | 11/06/26 | ||
| Yasmeen Rahimi | Piper Sandler | $51 | buy | 31.21%Upside | Reiterated | 11/06/26 | ||
| Lander Egana Gorrono | H.C. Wainwright | $45→$57 | buy | 46.64%Upside | Reiterated | 11/05/26 | ||
| Leonid Timashev | RBC Capital | $59 | buy | 51.79%Upside | Reiterated | 11/05/26 | ||
| James Condulis | Stifel Nicolaus | $36 | hold | -7.38%Downside | Reiterated | 11/05/26 | ||
| Martin Auster | Raymond James | $66→$85 | buy | 118.68%Upside | Reiterated | 11/05/26 | ||
| Cory Kasimov | Evercore ISI | $55 | buy | 41.50%Upside | Reiterated | 11/05/26 | ||
| Sharon Zackfia | William Blair | $53 | buy | 36.35%Upside | Initiated | 10/15/26 | ||
| Srikripa Devarakonda | Truist Financial | ― | buy | ― | Reiterated | 09/23/26 | ||
| Joseph Schwartz | Leerink Partners | ― | buy | ― | Reiterated | 09/23/26 | ||
| Paul Choi | Goldman Sachs | $36 | hold | -7.38%Downside | Reiterated | 09/22/26 | ||
| Tessa Romero | J.P. Morgan | $53→$60 | buy | 54.36%Upside | Assigned | 08/20/26 | ||
| Mazahir Alimohamed | Oppenheimer | $51 | buy | 31.21%Upside | Initiated | 07/09/26 | ||
| Debjit Chattopadhyay | Guggenheim | $41→$51 | buy | 31.21%Upside | Reiterated | 07/06/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Laura ChicoWedbush | BuyReiterated$51 | 11/06/26 | 31.21%Upside | ||
| Yasmeen RahimiPiper Sandler | BuyReiterated$51 | 11/06/26 | 31.21%Upside | ||
| Lander Egana GorronoH.C. Wainwright | BuyReiterated$45→$57 | 11/05/26 | 46.64%Upside | ||
| Leonid TimashevRBC Capital | BuyReiterated$59 | 11/05/26 | 51.79%Upside | ||
| James CondulisStifel Nicolaus | HoldReiterated$36 | 11/05/26 | -7.38%Downside | ||
| Martin AusterRaymond James | BuyReiterated$66→$85 | 11/05/26 | 118.68%Upside | ||
| Cory KasimovEvercore ISI | BuyReiterated$55 | 11/05/26 | 41.50%Upside | ||
| Sharon ZackfiaWilliam Blair | BuyInitiated$53 | 10/15/26 | 36.35%Upside | ||
| Srikripa DevarakondaTruist Financial | BuyReiterated | 09/23/26 | ― | ||
| Joseph SchwartzLeerink Partners | BuyReiterated | 09/23/26 | ― | ||
| Paul ChoiGoldman Sachs | HoldReiterated$36 | 09/22/26 | -7.38%Downside | ||
| Tessa RomeroJ.P. Morgan | BuyAssigned$53→$60 | 08/20/26 | 54.36%Upside | ||
| Mazahir AlimohamedOppenheimer | BuyInitiated$51 | 07/09/26 | 31.21%Upside | ||
| Debjit ChattopadhyayGuggenheim | BuyReiterated$41→$51 | 07/06/26 | 31.21%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Edgewise Therapeutics
3 Months
Success Rate14/22 ratings generated profit
64%
Average Return
+29.50%
Copying Laura Chico's trades and holding each position for 3 Months would result in 63.64% of your transactions generating a profit, with an average return of +29.50% per trade.
1 Year
Success Rate15/24 ratings generated profit
63%
Average Return
+44.92%
Copying Srikripa Devarakonda's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +44.92% per trade.
2 Years
Success Rate25/26 ratings generated profit
96%
Average Return
+98.70%
Copying Joseph Schwartz's trades and holding each position for 2 Years would result in 96.15% of your transactions generating a profit, with an average return of +98.70% per trade.
EWTX Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 0 | 1 | 3 |
| Buy | 24 | 20 | 15 | 15 | 14 |
| Hold | 4 | 5 | 4 | 4 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 32 | 28 | 19 | 20 | 19 |
In the current month, EWTX has received 17 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. EWTX average Analyst price target in the past 3 months is 54.30.
EWTX Financial Forecast
High$-0.25
Consensus$-0.44
Low$-0.60
EWTX Earnings Forecast
Next quarter’s earnings estimate for EWTX is -$0.44 with a range of -$0.60 to -$0.25. The previous quarter’s EPS was $9.65. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High$0.00
Consensus$0.00
Low$0.00
EWTX Sales Forecast
Next quarter’s sales forecast for EWTX is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
EWTX Stock Forecast FAQ
What is EWTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Edgewise Therapeutics’s 12-month average price target is $54.30.
What is EWTX’s upside potential, based on the analysts’ average price target?
Edgewise Therapeutics has 39.70% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is EWTX a Buy, Sell or Hold?
Edgewise Therapeutics has a consensus rating of Strong Buy which is based on 10 buy ratings, 2 hold ratings and 0 sell ratings.
What is Edgewise Therapeutics’s price target?
The average price target for Edgewise Therapeutics is $54.30. This is based on 12 12-month price targets, issued in the past 3 months. The highest analyst price target is $85.00, the lowest forecast is $36.00. The average price target represents a 39.70% increase from the current price of $38.87.
What do analysts say about Edgewise Therapeutics?
Edgewise Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Street analysts.
How can I buy shares of EWTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
